Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts

B. S. Moonga, O. A. Adebanjo, H. J. Wang, S. Li, X. B. Wu, B. Troen, A. Inzerillo, E. Abe, C. Minkin, C. L.H. Huang, M. Zaidi

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

The effects of the related cytokines interleukin-6 (IL-6), leukemia inhibitory factor (LIF) and oncostatin-M on bone resorption and cytosolic Ca2+ signaling were compared in isolated rat osteoclasts. In the traditional disaggregated osteoclast (pit) assay, IL-6 and LIF, but not oncostatin-M, conserved the bone resorption otherwise inhibited by high extracellular [Ca2+] (15 mM). It produced a paradoxical, concentration-dependent stimulation of resorption by elevated extracellular Ca2+. In the micro-isolated single osteoclast resorption assay, IL-6, high [Ca2+] or IL-6 plus high [Ca2+] all increased pit formation. In contrast, the IL-6 receptor (IL-6R)-specific agonist antibody MT-18 inhibited bone resorption in a concentration-dependent manner (1:500 to 1:500 000). MT-18 triggered cytosolic Ca2+ signals in fura 2-loaded osteoclasts within ∼ 10 min of application. Each cytosolic Ca2+ transient began with a peak deflection that persisted in Ca2+-free, EGTA-containing extracellular medium, consistent with a release of intracellularly stored Ca2+. This was followed by a sustained elevation of cytosolic [Ca2+] that was abolished in Ca2+-free medium, as expected from an entry of extracellular Ca2+, and by the Ca2+ channel antagonist Ni2+. The inclusion of either IL-6 or soluble human (sh) IL-6R specifically reversed both the above effects of MT-18, confirming that both effects were specific for the IL-6R. The findings suggest that IL-6R activation by IL-6 stimulates osteoclastic bone resorption either by reversing the inhibitory effect of high extracellular Ca2+ in stromal-containing systems or itself stimulating bone resorption along with Ca2+ by micro-isolated osteoclasts. In contrast, activation of the IL-6R by an agonist antibody produces an inhibition of bone resorption and an associated triggering of the cytosolic Ca2+ signals previously associated with regulation of bone resorptive function in other situations.

Original languageEnglish
Pages (from-to)395-405
Number of pages11
JournalJournal of Endocrinology
Volume173
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Dive into the research topics of 'Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts'. Together they form a unique fingerprint.

Cite this